Your browser doesn't support javascript.
loading
Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in NRAS-Mutant Melanoma Cell Lines.
Appleton, Kathryn M; Palsuledesai, Charuta C; Misek, Sean A; Blake, Maja; Zagorski, Joseph; Gallo, Kathleen A; Dexheimer, Thomas S; Neubig, Richard R.
Afiliação
  • Appleton KM; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA.
  • Palsuledesai CC; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA.
  • Misek SA; Department of Physiology, Michigan State University, East Lansing, MI 48824, USA.
  • Blake M; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA.
  • Zagorski J; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA.
  • Gallo KA; Department of Physiology, Michigan State University, East Lansing, MI 48824, USA.
  • Dexheimer TS; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA.
  • Neubig RR; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA.
Cancers (Basel) ; 13(9)2021 Apr 22.
Article em En | MEDLINE | ID: mdl-33921974

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article